FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/11/022146 [Registered on: 26/11/2019] Trial Registered Prospectively
Last Modified On: 17/06/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Single Arm Study 
Public Title of Study   To understand the Adverse Effect profile of a Food and Supplement-Based Detoxification Program in Healthy volunteers 
Scientific Title of Study   Safety of a Food and Supplement-Based Detoxification Program in Healthy Subjects 
Trial Acronym  CLEAN21 
Secondary IDs if Any  
Secondary ID  Identifier 
DCOI/CLEAN21-19/001;Version 1.0, Dated 02 October 2019  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Paul Salins 
Designation  Chairman 
Affiliation  CIMED  
Address  Room no 3, Second Floor, Plot No.2702, Pragati Plaza, Hebbagodi, Hosur Road

Bangalore
KARNATAKA
560099
India 
Phone  8071222999  
Fax    
Email  oncologyresearchnh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Alben Sigamani 
Designation  Consultant, Head Clinical Research 
Affiliation  Narayana Hrudayalaya 
Address  258/A, Bommasandra Industrial Area Anekal Taluk, Hosur Rd, Bengaluru

Bangalore
KARNATAKA
560099
India 
Phone  91-8071222999  
Fax    
Email  drsigamani@gmail.com  
 
Details of Contact Person
Public Query
 
Name  R C Parasher  
Designation  Sr. General Manager-Quality & NPD 
Affiliation  Organic India Pvt Ltd  
Address  Plot 266, Kamta,Near Crystal View Apartments Faizabad Road Kamata, Chinhat,

Lucknow
UTTAR PRADESH
226028
India 
Phone    
Fax    
Email  parasher@organicindia.com  
 
Source of Monetary or Material Support  
Composite Interceptive Med Science Laboratories Pvt. Ltd Plot No.2702, Room no 3, Second Floor, Pragati Plaza, Hebbagodi, Hosur Road 
 
Primary Sponsor  
Name  Organic India 
Address  Plot 266, Kamta, Near Crystal View Apartments, Faizabad Road, Chinhat, Lucknow-226028, Uttar Pradesh Karnataka  
Type of Sponsor  Other [Nutraceutical Company] 
 
Details of Secondary Sponsor  
Name  Address 
Composite interceptive Med Science Laboratories Pvt Ltd  2nd Floor Pragati Plaza, Hebbagodi, Hosur Road, Bangalore - 560099, Karnataka  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr L Sucharitha  Shettys Hospital  Room No. 1, First Floor, Dept. of Ayurveda, Plot No.11 &12, 12th F main, Kaveri Nagar, Bommanahalli
Bangalore
KARNATAKA 
08040416789

sucharitha.pandit@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Shettys Hospital Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  NA 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  CLEAN 21 Kit  This is a 21-day treatment program with kits that includes Smoothie packets (to be taken twice daily), wellness infusions (to be taken thrice after every major meal), and 5 types of supplements consisting of triphala, bowelcare, Neem, Turmeric, Liver and Kidney care capsules (to be taken thrice in a day, after each major meal), and Tulsi-lax to be taken only if the whole day goes by without bowel movement, either before bed or in the early morning 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Age above 21 years and below 65 years
2.Either gender
3.Literate Subjects (with English speaking skills) who are willing to consent for 21day program under supervision (telephonic and Social Network), self-motivated to complete the program
 
 
ExclusionCriteria 
Details  1.Know history of food allergies or positive for IgG for 22 known food allergens.
2.Women in child bearing age, married or potential to be pregnant, refusing to perform a pregnancy confirmation test to rule out pregnancy.
3.Women breast feeding or within 6 months post-partum.
4.Use of prescription and non-prescription medication and/or nutritional supplements/medical foods for the support of detoxification in the past 3 months or taking regular medication for diabetes, hypertension or dyslipidaemia and not showing adequate control as per standard guidelines or likely to have changes in their prescription during the 21 day program.
5.Anyone to have changed their physical activity significantly 2 weeks before the study and throughout the duration of the study.
6.Active disease undergoing intensive or continuation therapy for any illness.
7.Unlikely to be able to stay compliant to the program for reasons discussed with the clinician
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To compare the before and after CLEAN, metabolic detoxification score, among volunteers, without serious comorbid illness  Baseline, Visit 2 (Day 1), Visit 3 (Day 8) & Visit 4 (Day 15), Visit 5 (Day 22), and Visit 6 (Day 52)  
 
Secondary Outcome  
Outcome  TimePoints 
1.To compare the changes in baseline inflammatory screening panel, before and after CLEAN
2.To record incidence of any side effects to the CLEAN program
 
1.Baseline Visit & Visit 5 (22nd Day)
2. Baseline, Visit 2 (Day 1), Visit 3 (Day 8) & Visit 4 (Day 15), Visit 5 (Day 22), and Visit 6 (Day 52)


 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/11/2019 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   The Study outcome will be published by the sponsor after the completion of study. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This proposed study is a prospective, cohort, non-randomized single arm, pre- and post intervention study in healthy volunteers aged 21 to 65 Years. The primary endpoint is to establish the safety of a food and supplement based detoxification program among healthy subjects using the Metabolic Detoxification Questionnaire (MDQ). The  total number of visits include 21 days of detoxification and four weeks of washout.

 
Close